Skip to content

Kailera Therapeutics

US · KLRA #3073 by market cap Listed 2026
11.02 -0.56 -4.84%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

Momentum strategy signal
Hold
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 3 analysts

Buy
Avg price target 50.50 +358.3%
Price target rangecurrent 11.02
Low44.00
Avg50.50
High57.00
Buy 100% Hold 0% Sell 0%
Recent ratings (20)
DateFirmAnalystRatingTarget
2026-11-09 CCORF -- Buy 44.00
2026-09-30 William Blair -- Buy --
2026-09-29 TD Cowen -- Buy 57.00
2026-08-14 Jefferies -- Buy 48.00
2026-08-13 TD Cowen -- Buy 57.00
2026-08-12 William Blair -- Buy --
2026-08-12 J.P. Morgan -- Buy 30.00
2026-07-08 Jefferies -- Buy 48.00
2026-07-07 TD Cowen -- Buy 57.00
2026-07-07 William Blair -- Buy --
2026-05-28 Jefferies -- Buy 48.00
2026-05-27 William Blair -- Buy --
2026-05-26 TD Cowen -- Buy --
2026-05-21 TD Cowen -- Buy 57.00
2026-05-16 William Blair -- Buy --
2026-05-12 TD Cowen -- Buy 57.00
2026-05-12 William Blair -- Buy --
2026-05-12 Jefferies -- Buy 48.00
2026-05-12 Evercore -- Buy --
2026-05-12 J.P. Morgan -- Buy 30.00

Price target trend monthly average, last 3 years

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Kailera Therapeutics discussion 0 comments

Add a comment